Investigating the use of a fluorescent lectin to identify dysplasia and cancer during endoscopy and surgery

niversity of Oxford0 个研究点目标入组 50 人开始时间: 2017年4月7日最近更新: 2018年2月12日

适应症

试验速览

暂无简介。

•1. Participant is willing and able to give informed consent for participation in the study
•2. Male or female, aged 18 years or over
•3. Patients undergoing endoscopic procedures including colonoscopy and flexible sigmoidoscopy as well as transanal endoscopic microsurgery (TEMS), including robotic assisted TEMS
•4. In the investigator’s opinion, is able and willing to comply with all study requirements; 1. Participant is willing and able to give informed consent for participation in the study
•2. Male or female, aged 18 years or over
•3. Patients undergoing endoscopic procedures including colonoscopy and flexible sigmoidoscopy as well as transanal endoscopic microsurgery (TEMS), including robotic assisted TEMS
•4. In the investigator’s opinion, is able and willing to comply with all study requirements

•1. Patient who is unable or unwilling to give informed consent
•2. Female participant who is pregnant, lactating or planning pregnancy during the course of the trial. If there is an uncertainly regarding whether a woman could be pregnant, then they will be excluded from the study.
•3. Patients with known egg allergies, ovalbumin allergy and soya allergies; 1. Patient who is unable or unwilling to give informed consent
•2. Female participant who is pregnant, lactating or planning pregnancy during the course of the trial. If there is an uncertainly regarding whether a woman could be pregnant, then they will be excluded from the study.
•3. Patients with known egg allergies, ovalbumin allergy and soya allergies

发起方